查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美基因檢測服務市場預測至 2030 年 - 區域分析 - 按服務類型、疾病和服務提供者
市場調查報告書
商品編碼
1533072

北美基因檢測服務市場預測至 2030 年 - 區域分析 - 按服務類型、疾病和服務提供者

North America Genetic Testing Services Market Forecast to 2030 - Regional Analysis - by Service Type, Disease, and Service Provider
出版日期: | 出版商: The Insight Partners | 英文 101 Pages | 訂單完成後即時交付

價格

2022年北美基因檢測服務市值為16.0432億美元，預計到2030年將達到49.8425億美元；預計2022年至2030年複合年成長率為15.2%。

對直接面對消費者 (DTC) 的基因檢測的日益青睞推動了北美基因檢測服務市場的發展

個人化基因檢測和治療長期以來在全球範圍內使用，以幫助個人和家庭更多地了解遺傳性疾病。大多數時候，基因檢測是透過醫療保健人員（例如遺傳諮詢師）完成的。醫療保健提供者決定需要進行哪種測試，從測試中心訂購測試，收集並發送 DNA 樣本，讀取測試結果，並與患者分享結果。因此，這些測試傳統上是在臨床或醫學研究環境中進行排序和解釋的。相比之下，DTC 基因檢測在過去十年中取得了巨大的成長，並且變得越來越普遍。

由公司直接向消費者提供、宣傳和銷售的基因測試，無需傳統醫療保健系統的直接參與，稱為 DTC 基因測試。 DTC 基因檢測相對較新，可以幫助人們發現他們可能攜帶的與疾病相關的基因，而無需遺傳諮詢師或醫生的處方或指導。 DTC 測試的一些消費者將其視為收集有關自己的醫療資訊的另一種方法。

與診所或醫院進行的其他基因測試不同，消費者獨立啟動並完成 DTC 基因測試。大眾對基因檢測的理解和接受度正在逐漸提高。此外，越來越多的消費者尋求客製化產品和體驗來識別和滿足獨特需求。創新產品的推出以及 DTC 基因檢測試劑盒的採用增加，使基因檢測更容易被人們所接受。這些套件使用戶能夠在舒適的家中進行個人化的健康管理。

主要產業參與者也在開發 DTC 基因測試並實施特殊的行銷活動，以對 DTC 測試的銷售產生積極影響。 2017 年 4 月，美國食品藥物管理局 (FDA) 同意遺傳學公司 23andMe 銷售 DNA 測試，評估使用者罹患 10 種健康狀況的風險水平，包括遲發性阿茲海默症和帕金森氏症。這些仍然是 FDA 批准的唯一針對感染遺傳風險的 DTC 測試。 2023年7月，美國診斷資訊服務供應商Quest Diagnostics推出了首款直接面對消費者的基因測試Genetic Insights。該測試使用次世代定序來評估遺傳健康狀況的風險。此測試使用唾液樣本檢查 36 個基因。它可以調查多達 24 種遺傳性疾病的潛在風險，包括乳癌、心臟病、血液疾病和鐮狀細胞性貧血。

越來越多的製造商正在提供直接面對消費者的基因檢測，涵蓋各種健康狀況和特徵。對直接面對消費者的基因檢測產品的需求不斷成長，以了解基因組成並評估遺傳性疾病的風險，以進行早期疾病檢測或預防，這推動了市場的發展。

北美基因檢測服務市場概況

北美基因檢測服務市場分為美國、加拿大和墨西哥。 2022年，美國在該地區佔據最大市場佔有率，預計2022-2030年將繼續保持主導地位。近年來，由於癌症患者數量不斷增加、政府資助不斷增加以及美國和加拿大人口遺傳疾病發病率上升，北美基因檢測服務市場預計將成長。此外，對醫療保健中先進方法整合的日益關注、政府和私人促進精準醫療的舉措，以及政府和私人機構為基因研究提供的大量資金，都為北美基因檢測服務市場帶來了非凡的收入。

北美基因檢測服務市場收入及 2030 年預測（百萬美元）

北美基因檢測服務市場細分

北美基因檢測服務市場按服務類型、疾病、服務提供者和國家分類。

根據服務類型，北美基因檢測服務市場可細分為預測檢測、帶因者檢測、產前檢測、新生兒篩檢等。預測測試領域在 2022 年佔據最大的市場佔有率。

從疾病類型來看，北美基因檢測服務市場分為癌症、代謝疾病、心血管疾病和其他疾病。 2022 年，癌症細分市場佔據最大的市場。

依服務提供者分類，北美基因檢測服務市場分為醫院實驗室、診斷實驗室等。 2022 年，醫院實驗室細分市場佔據最大市場佔有率。

按國家/地區分類，北美基因檢測服務市場分為美國、加拿大和墨西哥。 2022年，美國在北美基因檢測服務市場佔有率中佔據主導地位。

23andMe Holding Co、Ambry Genetics Corp、Eurofins Scientific SE、Exact Sciences Corp、F. Hoffmann-La Roche Ltd、Illumina Inc、Laboratory Corp of America Holdings、NeoGenomics Inc、Centogene AG 和Quest Diagnostics Inc 是在這些領域營運的領先公司之一。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美基因檢測服務市場 - 主要產業動態

  • 主要市場促進因素
    • 遺傳性疾病盛行率上升
    • 提高對個人化藥物的認知和接受度
    • 對直接面對消費者 (DTC) 的基因檢測的偏好日益成長
  • 市場限制
    • 基因檢測的社會和倫理影響
    • 遺傳服務的承受能力
  • 市場機會
    • 發展中國家尚未開發的新興市場
  • 未來趨勢
    • 人工智慧驅動的基因檢測
  • 影響分析：

第 5 章：基因檢測服務市場 - 北美市場分析

  • 北美基因檢測服務市場收入，2022 - 2030

第 6 章：北美基因檢測服務市場 - 收入和 2030 年預測 - 按服務類型

  • 概述
  • 北美基因檢測服務市場收入佔有率，按服務類型，2022 年和 2030 年 (%)
  • 預測測試
  • 營運商測試
  • 產前檢測
  • 新生兒篩檢
  • 其他

第 7 章：北美基因檢測服務市場 - 2030 年收入與預測 - 按疾病分類

  • 概述
  • 北美基因檢測服務市場收入佔有率，按疾病分類，2022 年和 2030 年 (%)
  • 癌症
  • 心血管疾病
  • 代謝性疾病
  • 其他疾病

第 8 章：北美基因檢測服務市場 - 收入和 2030 年預測 - 按服務提供者

  • 概述
  • 2022 年和 2030 年北美基因檢測服務市場收入佔有率（按服務提供者分類）（%）
  • 醫院實驗室
  • 診斷實驗室
  • 其他

第 9 章：北美基因檢測服務市場 - 國家分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第 10 章：基因檢測服務市場-產業格局

  • 概述
  • 基因檢測服務市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 11 章：公司簡介

  • Eurofins Scientific SE
  • Exact Sciences Corp
  • Laboratory Corp of America Holdings
  • 23andMe Holding Co
  • Ambry Genetics Corp
  • Quest Diagnostics Inc
  • Illumina Inc
  • F. Hoffmann-La Roche Ltd
  • NeoGenomics Inc
  • Centogene AG

第 12 章：附錄

Product Code: TIPRE00009262

The North America genetic testing services market was valued at US$ 1,604.32 million in 2022 and is expected to reach US$ 4,984.25 million by 2030; it is estimated to register a CAGR of 15.2% from 2022 to 2030.

Growing Preference for Direct-To-Consumer (DTC) Genetic Testing Fuels North America Genetic Testing Services Market

Personalized genetic testing and treatment have long been used globally to help individuals and families learn more about hereditary diseases. Most of the time, genetic testing is done through healthcare personnel, such as genetic counselors. Healthcare providers decide which test is needed, order the test from a test center, collect and send the DNA sample, read the test results, and share the results with the patient. Thus, these tests have traditionally been ordered and interpreted in a clinical or medical research setting. In contrast, DTC genetic testing has witnessed tremendous growth in the past decade and is becoming increasingly widespread.

A genetic test offered, advertised, and sold by companies directly to the consumer, without the direct involvement of a conventional healthcare system, is called DTC genetic testing. DTC genetic testing is relatively new and helps people find out about the disease-associated genes they may carry without the need for a prescription or guidance from a genetic counselor or medical practitioner. Several consumers of DTC testing view it as another method of gathering medical information about themselves.

Unlike other genetic tests performed in clinics or hospitals, the consumer independently initiates and completes a DTC genetic test. The public understanding and acceptance of genetic testing is gradually increasing. Additionally, there is a rise in consumers seeking customized products and experiences for the identification and addressing of unique needs. The launch of innovative products and the increase in the adoption of DTC genetic testing kits have made genetic testing more accessible to people. These kits enable users to undergo personalized health management within the comfort of their homes.

Key industry players are also developing DTC genetic tests and implementing special marketing efforts that positively impact sales of DTC tests. In April 2017, the US Food and Drug Administration (FDA) gave genetics company 23andMe the consent to market DNA tests evaluating the user's level of risk for ten health conditions, including late-onset Alzheimer's disease and Parkinson's disease. These remain the only FDA-approved DTC tests for genetic risk of infection. In July 2023, Quest Diagnostics, a US-based diagnostic information service provider, introduced its first direct-consumer genetic test, Genetic Insights. The test uses next-generation sequencing to evaluate the risk for inheritable health conditions. The test inspects 36 genes using a saliva sample. It can investigate the potential risk of up to 24 genetically inheritable conditions, including breast cancer, heart disorders, blood disorders, and sickle cell anemia.

A rising number of manufacturers are providing direct-to-consumer genetic testing that covers various health conditions and traits. The increasing demand for direct-to-consumer genetic testing products to learn about the genetic makeup and assess the risk of developing hereditary conditions for early disease detection or prevention drives the market.

North America Genetic Testing Services Market Overview

The North America genetic testing services market in North America is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during 2022-2030. The North America genetic testing services market in North America is expected to grow due to the rising number of cancer patients, increasing government funding, and rising incidence of genetic diseases among the population in the US and Canada during recent years. Moreover, increasing focus on advanced method incorporation in healthcare, government and private initiatives for the promotion of precision medicine, and massive funds from government and private bodies for genetic research contribute to exceptional revenue generation for the North America genetic testing services market in North America.

North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Million)

North America Genetic Testing Services Market Segmentation

The North America genetic testing services market is categorized into service type, disease, service provider, and country.

Based on service type, the North America genetic testing services market is segmented predictive testing, carrier testing, prenatal testing, newborn screening, and others. The predictive testing segment held the largest market share in 2022.

In terms of disease, the North America genetic testing services market is categorized into cancer, metabolic diseases, cardiovascular diseases, and other diseases. The cancer segment held the largest market share in 2022.

By service provider, the North America genetic testing services market is segmented into hospital-based laboratories, diagnostic laboratories, and others. The hospital-based laboratories segment held the largest market share in 2022.

By country, the North America genetic testing services market is segmented into the US, Canada, and Mexico. The US dominated the North America genetic testing services market share in 2022.

23andMe Holding Co, Ambry Genetics Corp, Eurofins Scientific SE, Exact Sciences Corp, F. Hoffmann-La Roche Ltd, Illumina Inc, Laboratory Corp of America Holdings, NeoGenomics Inc, Centogene AG, and Quest Diagnostics Inc are among the leading companies operating in the North America genetic testing services market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Genetic Testing Services Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Rising Prevalence of Genetic Diseases
    • 4.1.2 Increasing Awareness and Acceptance of Personalized Medicines
    • 4.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
  • 4.2 Market Restraints
    • 4.2.1 Social and Ethical Implications of Genetic Testing
    • 4.2.2 Affordability of Genetic Services
  • 4.3 Market Opportunities
    • 4.3.1 Untapped Emerging Markets in Developing Countries
  • 4.4 Future Trends
    • 4.4.1 Artificial Intelligence-Powered Genetic Testing
  • 4.5 Impact Analysis:

5. Genetic Testing Services Market - North America Market Analysis

  • 5.1 North America Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030

6. North America Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Type

  • 6.1 Overview
  • 6.2 North America Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
  • 6.3 Predictive Testing
    • 6.3.1 Overview
    • 6.3.2 Predictive Testing: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Carrier Testing
    • 6.4.1 Overview
    • 6.4.2 Carrier Testing: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Prenatal Testing
    • 6.5.1 Overview
    • 6.5.2 Prenatal Testing: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Newborn Screening
    • 6.6.1 Overview
    • 6.6.2 Newborn Screening: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Genetic Testing Services Market - Revenue and Forecast to 2030 - by Disease

  • 7.1 Overview
  • 7.2 North America Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
  • 7.3 Cancer
    • 7.3.1 Overview
    • 7.3.2 Cancer: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Cardiovascular Diseases
    • 7.4.1 Overview
    • 7.4.2 Cardiovascular Diseases: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Metabolic Diseases
    • 7.5.1 Overview
    • 7.5.2 Metabolic Diseases: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Other Diseases
    • 7.6.1 Overview
    • 7.6.2 Other Diseases: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Genetic Testing Services Market - Revenue and Forecast to 2030 - by Service Provider

  • 8.1 Overview
  • 8.2 North America Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
  • 8.3 Hospital-Based Laboratories
    • 8.3.1 Overview
    • 8.3.2 Hospital-Based Laboratories: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Diagnostic Laboratories
    • 8.4.1 Overview
    • 8.4.2 Diagnostic Laboratories: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Genetic Testing Services Market - Country Analysis

  • 9.1 North America
    • 9.1.1 North America Genetic Testing Services Market, by Country
      • 9.1.1.1 US
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 US: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.1.3 US: North America Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.1.4 US: North America Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.1.5 US: North America Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 9.1.1.2 Canada
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 Canada: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.3 Canada: North America Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.2.4 Canada: North America Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.2.5 Canada: North America Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)
      • 9.1.1.3 Mexico
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 Mexico: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.3 Mexico: North America Genetic Testing Services Market, by Service Type, 2020-2030 (US$ Million)
        • 9.1.1.3.4 Mexico: North America Genetic Testing Services Market, by Disease, 2020-2030 (US$ Million)
        • 9.1.1.3.5 Mexico: North America Genetic Testing Services Market, by Service Provider, 2020-2030 (US$ Million)

10. Genetic Testing Services Market-Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Genetic Testing Services Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Eurofins Scientific SE
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Exact Sciences Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Laboratory Corp of America Holdings
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 23andMe Holding Co
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Ambry Genetics Corp
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Quest Diagnostics Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Illumina Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 F. Hoffmann-La Roche Ltd
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 NeoGenomics Inc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Centogene AG
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. North America Genetic Testing Services Market Segmentation
  • Table 2. US: North America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US: North America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US: North America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Canada: North America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Canada North America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Canada: North America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Mexico: North America Genetic Testing Services Market, by Service Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Mexico: North America Genetic Testing Services Market, by Disease - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Mexico: North America Genetic Testing Services Market, by Service Provider - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Recent Organic Growth Strategies in Genetic Testing Services Market
  • Table 12. Recent Inorganic Growth Strategies in the Genetic Testing Services Market
  • Table 13. Glossary of Terms, Genetic Testing Services Market

List Of Figures

  • Figure 1. North America Genetic Testing Services Market Segmentation, By Country
  • Figure 2. North America Genetic Testing Services Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Genetic Testing Services Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. North America Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
  • Figure 6. Predictive Testing: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Carrier Testing: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Prenatal Testing: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Newborn Screening: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. North America Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
  • Figure 12. Cancer: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cardiovascular Diseases: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Metabolic Diseases: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Other Diseases: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. North America Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
  • Figure 17. Hospital-Based Laboratories: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Diagnostic Laboratories: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: North America Genetic Testing Services Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Genetic Testing Services Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 21. North America Genetic Testing Services Market, By Key Countries, 2022 and 2030 (%)
  • Figure 22. US: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 23. Canada: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Mexico: North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Growth Strategies in Genetic Testing Services Market